drugset / Trial / NCT01894555
Pharmacogenomics of Antiplatelet Response - II (PARes-II)
NaSingle-groupOpen-labelBasic science
Summary
This clinical trial is examining the effect of 4-week aspirin therapy on platelet transcriptome in persons at high-risk for myocardial infarction or stroke due to family history of early-onset coronary artery disease.
Timeline
- Start
- 2013-01
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |